Sign In
Buy GLP
$48.45
-0.81 (-1.64%)
At Close: Jun 03, 2026
Company announcement – No. 27 / 2024 Zealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low doses of GLP-1/GLP-2 receptor dual agonist dapiglutide Mean w
Victory Square Company Announces Access to Tirzepatide and GLP-1 Injections to its Weight Loss Portfolio
07:45am, Thursday, 23'rd May 2024
Hydreight Technologies announced the addition of Tirzepatide to its weight loss portfolio which also includes GLP-1 injections, giving patients a cost-effective way to access safe, high quality diabet
Amid ‘Ozempic babies' questions, women account for more than 75% of young adults taking GLP-1 drugs, study finds
11:04am, Wednesday, 22'nd May 2024
More than three out of four young adults prescribed GLP-1 drugs last year were women, new research shows, raising questions about how societal views of women's weight may influence use of these medica
Hims & Hers Health stock price nears record high on news that it will offer GLP-1 weight-loss drugs amid shortages
10:51am, Tuesday, 21'st May 2024
Hims & Hers Health got a shot in the arm this week that sent its share prices to near all-time highs.
Roundhill Investments Launches GLP-1 & Weight Loss ETF (OZEM)
09:00am, Tuesday, 21'st May 2024
OZEM provides exposure to the rapidly growing weight loss management market, which is expected to reach $100 billion by 2030. NEW YORK , May 21, 2024 /PRNewswire/ -- Roundhill Investments, an ETF spon
MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications
08:30am, Tuesday, 21'st May 2024
Formulations to be marketed as “Slim” and “Trim” as an Oral Dissolvable Tablet (ODT) Dallas, TX, May 21, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “C
Hims & Hers: Soaring On Access To Compounded GLP-1 Drugs, Further Volatility Ahead
08:15am, Tuesday, 21'st May 2024
Hims & Hers Health's share price increased by over 25% after announcing the availability of compounded GLP-1 agonist weight loss drugs at a fraction of the price of branded drugs. The company aims to
Nestle to launch Vital Pursuit frozen-food brand targeting GLP-1 users
07:41am, Tuesday, 21'st May 2024
Nestle's Vital Pursuit brand's initial lineup of 12 items will include frozen bowls with whole grains or protein pasta, sandwich melts and pizzas.
Dr. Craig Primack talks Hims & Hers launching its own GLP-1 offering as demand rises
06:43pm, Monday, 20'th May 2024
Dr. Craig Primack, Hims & Hers SVP of Weight Management, joins 'Closing Bell Overtime' to talk the company offering a GLP-1 drug through its platform.
BGL Announces the Recapitalization of Musser Biomass and Wood Products by Watermill Group
05:17pm, Monday, 20'th May 2024
Musser is a provider of ESG-certified engineered biomass wood fiber products CLEVELAND, May 20, 2024 /PRNewswire/ -- Brown Gibbons Lang & Company (BGL) is pleased to announce the recapitalization of M
Hims & Hers Health Stock Jumps Nearly 28% on Plans to Offer GLP-1 Weight-Loss Drugs
05:15pm, Monday, 20'th May 2024
Shares of Hims & Hers Health (HIMS) surged close to 28% Monday after the telehealth company said it would begin offering GLP-1 injections as part of its weight-loss package of drugs.
Hims & Hers rallies after announcing access to GLP-1 injections
12:23pm, Monday, 20'th May 2024
Hims & Hers Health Inc shares rocketed 31% higher on Monday after announcing it will provide access to injectable GLP-1 medications. These injections serve as a more affordable alternative to branded
Hims & Hers Health says it will offer compounded GLP-1 drugs, despite FDA warnings
12:01pm, Monday, 20'th May 2024
Hims & Hers Health Inc.'s stock HIMS, +32.81% jumped more than 30% Monday morning after the health and wellness platform said it would offer compounded GLP-1 drugs — products that the Food and Drug
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
09:00am, Monday, 20'th May 2024
The GLP-1 market has faced supply constraints in recent months as the drugs like Ozempic and Wegovy skyrocket in popularity.
Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers
09:00am, Monday, 20'th May 2024
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc., the leading health and wellness platform, today announced the addition of GLP-1 injections to its comprehensive weight loss portfolio, giving
